Equities

Reuters details how China cash flooding U.S. biotech startups

Reuters details how China cash flooding U.S. biotech startups

In an in-depth report, Reuters detailed how billions of dollars are flowing from China to fund U.S. biotech startups in a bet on the growth potential of China’s prescription-drug market and its biotech sector.